colon: Chemotherapy for Stage B/C colon cancer
In survival: Survival Analysis
colon R Documentation
Chemotherapy for Stage B/C colon cancer
Description
These are data from one of the first successful trials of
adjuvant chemotherapy for colon cancer. Levamisole is a low-toxicity
compound previously used to treat worm infestations in animals; 5-FU
is a moderately toxic (as these things go) chemotherapy agent. There
are two records per person, one for recurrence and one for death
Usage
colon
data(cancer, package="survival")
Format
id: id
study: 1 for all patients
rx: Treatment - Obs(ervation), Lev(amisole), Lev(amisole)+5-FU
sex: 1=male
age: in years
obstruct: obstruction of colon by tumour
perfor: perforation of colon
adhere: adherence to nearby organs
nodes: number of lymph nodes with detectable cancer
time: days until event or censoring
status: censoring status
differ: differentiation of tumour (1=well, 2=moderate, 3=poor)
extent: Extent of local spread (1=submucosa, 2=muscle, 3=serosa,
4=contiguous structures)
surg: time from surgery to registration (0=short, 1=long)
node4: more than 4 positive lymph nodes
etype: event type: 1=recurrence,2=death
Note
The study is originally described in Laurie (1989).
The main report is found in Moertel (1990). This data set is closest
to that of the final report in Moertel (1991).
A version of the data with less follow-up time was used in the
paper by Lin (1994).
Peter Higgins has pointed out a data inconsistency, revealed by
table(colon$nodes, colon$node4). We don't know which of the
two variables is actually correct so have elected not to 'fix' it.
(Real data has warts, why not have some in the example data too?)
References
JA Laurie, CG Moertel, TR Fleming, HS Wieand, JE Leigh, J Rubin,
GW McCormack, JB Gerstner, JE Krook and J Malliard. Surgical
adjuvant therapy of large-bowel carcinoma: An evaluation of
levamisole and the combination of levamisole and fluorouracil:
The North Central Cancer Treatment Group and the Mayo Clinic.
J Clinical Oncology, 7:1447-1456, 1989.
DY Lin. Cox regression analysis of multivariate failure time data:
the marginal approach. Statistics in Medicine, 13:2233-2247, 1994.
CG Moertel, TR Fleming, JS MacDonald,
DG Haller, JA Laurie, PJ Goodman, JS Ungerleider,
WA Emerson, DC Tormey, JH Glick, MH Veeder and JA Maillard.
Levamisole and fluorouracil for adjuvant therapy of
resected colon carcinoma. New England J of Medicine, 332:352-358,
1990.
CG Moertel, TR Fleming, JS MacDonald, DG Haller, JA Laurie, CM Tangen,
JS Ungerleider, WA Emerson, DC Tormey, JH Glick, MH Veeder and JA
Maillard, Fluorouracil plus Levamisole as an effective adjuvant
therapy after resection of stage II colon carcinoma: a final report.
Annals of Internal Med, 122:321-326, 1991.
survival documentation built on June 22, 2024, 10:49 a.m.
R Package Documentation
Browse R Packages
We want your feedback!
Note that we can't provide technical support on individual packages. You should contact the package authors for that.
| colon | R Documentation |
Chemotherapy for Stage B/C colon cancer
Description
These are data from one of the first successful trials of adjuvant chemotherapy for colon cancer. Levamisole is a low-toxicity compound previously used to treat worm infestations in animals; 5-FU is a moderately toxic (as these things go) chemotherapy agent. There are two records per person, one for recurrence and one for death
Usage
colon
data(cancer, package="survival")
Format
| id: | id |
| study: | 1 for all patients |
| rx: | Treatment - Obs(ervation), Lev(amisole), Lev(amisole)+5-FU |
| sex: | 1=male |
| age: | in years |
| obstruct: | obstruction of colon by tumour |
| perfor: | perforation of colon |
| adhere: | adherence to nearby organs |
| nodes: | number of lymph nodes with detectable cancer |
| time: | days until event or censoring |
| status: | censoring status |
| differ: | differentiation of tumour (1=well, 2=moderate, 3=poor) |
| extent: | Extent of local spread (1=submucosa, 2=muscle, 3=serosa, 4=contiguous structures) |
| surg: | time from surgery to registration (0=short, 1=long) |
| node4: | more than 4 positive lymph nodes |
| etype: | event type: 1=recurrence,2=death |
Note
The study is originally described in Laurie (1989). The main report is found in Moertel (1990). This data set is closest to that of the final report in Moertel (1991). A version of the data with less follow-up time was used in the paper by Lin (1994).
Peter Higgins has pointed out a data inconsistency, revealed by
table(colon$nodes, colon$node4). We don't know which of the
two variables is actually correct so have elected not to 'fix' it.
(Real data has warts, why not have some in the example data too?)
References
JA Laurie, CG Moertel, TR Fleming, HS Wieand, JE Leigh, J Rubin, GW McCormack, JB Gerstner, JE Krook and J Malliard. Surgical adjuvant therapy of large-bowel carcinoma: An evaluation of levamisole and the combination of levamisole and fluorouracil: The North Central Cancer Treatment Group and the Mayo Clinic. J Clinical Oncology, 7:1447-1456, 1989.
DY Lin. Cox regression analysis of multivariate failure time data: the marginal approach. Statistics in Medicine, 13:2233-2247, 1994.
CG Moertel, TR Fleming, JS MacDonald, DG Haller, JA Laurie, PJ Goodman, JS Ungerleider, WA Emerson, DC Tormey, JH Glick, MH Veeder and JA Maillard. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. New England J of Medicine, 332:352-358, 1990.
CG Moertel, TR Fleming, JS MacDonald, DG Haller, JA Laurie, CM Tangen, JS Ungerleider, WA Emerson, DC Tormey, JH Glick, MH Veeder and JA Maillard, Fluorouracil plus Levamisole as an effective adjuvant therapy after resection of stage II colon carcinoma: a final report. Annals of Internal Med, 122:321-326, 1991.
R Package Documentation
Browse R Packages
We want your feedback!
Note that we can't provide technical support on individual packages. You should contact the package authors for that.
Embedding an R snippet on your website
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.